Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
The Food and Drug Administration on Friday granted approval for the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy.
The pill is taken once a day for 14 days.
“Having access to an oral medication will be a beneficial option for many of these women coping with extreme, and sometimes life-threatening, feelings,” said Dr. Tiffany Farchione, FDA’s director of psychiatric drugs, in a statement.
Postpartum depression affects an estimated 400,000 people a year, and while it often ends on its own within a couple weeks, it can continue for months or even years. Standard treatment includes counseling or antidepressants, which can take weeks to work and don’t help everyone.
The new pill is from Sage Therapeutics, which has a similar infused drug that’s given intravenously over three days in a medical facility. The FDA approved that drug in 2019, though it isn’t widely used because of its $34,000 price tag and the logistics of administering it.
The FDA’s pill approval is based on two company studies that showed women who took Zurzuvae had fewer signs of depression over a four- to six-week period when compared with those who received a dummy pill. The benefits, measured using a psychiatric test, appeared within three days for many patients.
Sahar McMahon, 39, had never experienced depression until after the birth of her second daughter in late 2021. She agreed to enroll in a study of the drug, known chemically as zuranolone, after realizing she no longer wanted to spend time with her children.
“I planned my pregnancies, I knew I wanted those kids but I didn’t want to interact with them,” said McMahon, who lives in New York City. She says her mood and outlook started improving within days of taking the first pills.
“It was a quick transition for me just waking up and starting to feel like myself again,” she said.
Dr. Kimberly Yonkers of Yale University said the Zurzuvae effect is “strong” and the drug likely will be prescribed for women who haven’t responded to antidepressants. She wasn’t involved in testing the drug.
Still, she said, the FDA should have required Sage to submit more follow-up data on how women fared after additional months.
“The problem is we don’t know what happens after 45 days,” said Yonkers, a psychiatrist who specializes in postpartum depression. “It could be that people are well or it could be that they relapse.”
Sage did not immediately announce how it would price the pill, and Yonkers said that’ll be a key factor in how widely its prescribed.
Side effects with the new drug are milder than the IV version, and include drowsiness and dizziness. The drug was co-developed with fellow Massachusetts pharmaceutical company Biogen.
Both the pill and IV forms mimic a derivative of progesterone, the naturally occurring female hormone needed to maintain a pregnancy. Levels of the hormone can plunge after childbirth.
Sage’s drugs are part of an emerging class of medications dubbed neurosteroids. These stimulate a different brain pathway than older antidepressants that target serotonin, the chemical linked to mood and emotions.
Latest Stories
-
FirstBank Ghana expands footprint with new Nhyiaeso branch
3 mins -
FirstBank Ghana pays courtesy call on Asantehene ahead of Nhyiaeso branch commissioning
8 mins -
CAF President blasts Ghana over Baba Yara stadium ban
12 mins -
GUTA calls for de-politicization of fight against galamsey
13 mins -
Police outlines guidelines for NDC’s nationwide demonstration against EC
28 mins -
Demystifying the claims of rip-offs and arbitrary charges in Ghana’s port sector—from the shipping lines perspective
39 mins -
EducationUSA: Ghanaian students in US benefit from $9 million Investment
53 mins -
Elections not about insults; be decent in your speech – Bawumia to Mahama
58 mins -
Reverse osmosis the most reliable way to filter water – Association of Packaged Water Producers
1 hour -
UG SRC Presidential Race: Court ruling has taught me a lot about life – Guru
1 hour -
Voazok Tours to hold Canada Agricultural Tour
2 hours -
Peace Council implements measures to ensure peaceful 2024 elections
2 hours -
Staff of banks involved in fraud increases by 46% in 2023; BoG expresses worry
2 hours -
NDC calls for public support for upcoming protest – W/R NDC Secretary
2 hours -
2024/25 GPL: Vision FC secure 2-0 maiden GPL win against Accra Lions
2 hours